Cholescintigraphy (HIDA)⁹⁹ᵐTc-mebrofenin / disofenin (IDA agents)

Quick Answer

Cholescintigraphy (HIDA) tracks a hepatocyte-extracted, biliary-excreted IDA agent (Tc-99m-mebrofenin/disofenin) through liver → bile ducts → gallbladder → bowel. Its highest-value use is acute cholecystitis: non-visualization of the gallbladder at 60 min (and after morphine or 3–4 h delay) with preserved bile-duct/bowel activity indicates cystic-duct obstruction — the most sensitive test for acute cholecystitis. Other roles: bile-leak detection (extraluminal tracer), biliary atresia (no bowel excretion after phenobarbital priming), CCK gallbladder ejection fraction for chronic acalculous disease, and sphincter-of-Oddi/biliary-enteric assessment.

Background & Mechanism

IDA (iminodiacetic acid) agents are taken up by hepatocytes (competing with bilirubin) and excreted unchanged into bile — imaging the same pathway as bilirubin without conjugation. Mebrofenin has high hepatic extraction and resists displacement by bilirubin, so it performs better in hyperbilirubinemia than older agents. Normal sequence: prompt hepatic uptake, duct and gallbladder filling, and bowel activity, typically within 60 minutes.

Acute Cholecystitis — the Core Study

• Positive (acute cholecystitis): gallbladder non-visualization at 60 min that persists after morphine augmentation (0.04 mg/kg — contracts the sphincter of Oddi, raising ductal pressure to fill a patent cystic duct) or on 3–4 h delayed images — indicating cystic-duct obstruction.
• Negative: gallbladder fills → cystic duct patent → acute cholecystitis excluded.
• Rim sign: increased pericholecystic hepatic activity — associated with complicated/gangrenous cholecystitis.
• Highest sensitivity/specificity for acute cholecystitis among imaging tests (ultrasound is first-line but HIDA resolves equivocal cases).

Other Applications

• Bile leak: progressive extraluminal/free tracer (post-cholecystectomy, trauma) — SPECT/CT localizes.
• Biliary atresia (neonatal): phenobarbital priming (5 days) enhances excretion; no bowel activity on delayed (up to 24 h) images supports atresia (good hepatic uptake but no gut excretion) — vs neonatal hepatitis (delayed but present excretion).
• Chronic acalculous cholecystitis / gallbladder dyskinesia: CCK-stimulated gallbladder ejection fraction (GBEF); a low GBEF (<~35–38%) supports functional gallbladder disease.
• Sphincter of Oddi / biliary-enteric anastomosis patency and post-transplant biliary complications.

Preparation & Protocol

• Fasting 4–6 h (a contracted, recently-fed gallbladder won't fill → false positive); but not > ~24 h fasting/TPN (a distended, sludge-filled gallbladder also won't fill → false positive) — consider pre-treatment CCK (sincalide) to empty it first.
• Morphine augmentation or 3–4 h delayed imaging when the gallbladder is non-visualized at 60 min.
• Phenobarbital priming for suspected biliary atresia.
• CCK/sincalide infusion for GBEF (standardized slow infusion).

Interpretation & Reporting

• Report gallbladder visualization/timing, response to morphine/delay, bowel activity, any leak, and GBEF where measured.
• State fasting status and any CCK/phenobarbital preparation (validity depends on it).

Common Pitfalls

• Inadequate fasting (recent meal → contracted GB → false positive) or prolonged fasting/TPN (distended GB → false positive) — use CCK pretreatment.
• Calling cholecystitis without morphine or delayed imaging (delayed filling missed).
• Hyperbilirubinemia degrading hepatic uptake (mebrofenin more robust).
• Missing a subtle bile leak without SPECT/CT.

Board Pearls

Cholescintigraphy tracks a hepatocyte-extracted, biliary-excreted IDA agent through liver → gallbladder → bowel. For acute cholecystitis, gallbladder non-visualization at 60 min persisting after morphine or 3–4 h delay (with preserved ductal/bowel activity) indicates cystic-duct obstruction — the most sensitive test. Morphine contracts the sphincter of Oddi to fill a patent cystic duct; the rim sign flags complicated/gangrenous disease.

Fasting matters both ways: too little (recent meal) contracts the gallbladder and too much (>24 h / TPN) distends it — both cause false-positive non-filling; pre-treat with CCK/sincalide when needed. For neonatal biliary atresia, phenobarbital priming then absent bowel activity on delayed images supports atresia (good uptake, no excretion) versus neonatal hepatitis.

CCK-stimulated gallbladder ejection fraction (GBEF) assesses chronic acalculous cholecystitis / dyskinesia — a low GBEF (<~35–38%) supports functional disease. Mebrofenin resists bilirubin displacement (better in hyperbilirubinemia). HIDA also detects bile leaks (extraluminal tracer, SPECT/CT) and assesses sphincter of Oddi / biliary-enteric patency and post-transplant complications.

Related Pages

• Tracer: Tc-99m-IDA agents (HIDA); related: Liver-spleen imaging; pitfalls: Pearls, pitfalls & normal variants.

Figure / Diagram Suggestions

• A normal hepatobiliary sequence timeline (uptake → GB → bowel) vs non-visualization.
• A morphine-augmentation decision flow (60-min non-visualization → morphine/delay).
• A biliary-atresia vs neonatal-hepatitis delayed-imaging comparison.

Self-Check